title: Male breast cancer in LAUTECH Teaching Hospital Osogbo, South Western Nigeria.
abstract: OBJECTIVE
  To assess the prevalence, presentation, treatment and outcome of management of male breast cancer (MBC) in Osogbo, Nigeria.
  
  
  METHODS
  A review of all cases of MBC seen at LAUTECH Teaching Hospital Osogbo between January 2004 and December 2006 was done. The age, presenting symptoms and signs, stage, histology, associated co-morbid illnesses, treatment and outcome of care were all retrieved and analysed.
  
  
  RESULTS
  Seven (8.86%) out of seventy nine cases of breast cancers seen are males. Ages ranged between 38 and 80 years (mean 60.5 median 65 years). They all presented with advanced lesions after a 6 -36 months delay (mean-11.57 months). All were invasive ductal carcinoma. All the four with significant co-morbid illnesses died of them within one week to seven months. Only one patient had mastectomy.
  
  
  CONCLUSIONS
  MBC constitutes 8.86% of all breast cancer, all presented late with advanced lesions and co-morbid illnesses contributed significantly to mortality.
authors.affiliation: Department of Surgery, LAUTECH Teaching Hospital, Osogbo, Nigeria.
authors.forename: A S
authors.initials: AS
authors.lastname: Oguntola
authors.forename: A O A
authors.initials: AO
authors.lastname: Aderonmu
authors.forename: M L
authors.initials: ML
authors.lastname: Adeoti
authors.forename: S A
authors.initials: SA
authors.lastname: Olatoke
authors.forename: O
authors.initials: O
authors.lastname: Akanbi
authors.forename: S O
authors.initials: SO
authors.lastname: Agodirin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018567:Breast Neoplasms, Male / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D015897:Comorbidity; D006784:Hospitals, Teaching; D006801:Humans; D008297:Male; D008408:Mastectomy; D008875:Middle Aged; D009549:Nigeria / Q000453:epidemiology; D015995:Prevalence; D012189:Retrospective Studies; D016019:Survival Analysis; D013629:Tamoxifen / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D013629:Tamoxifen